Skip to main content
. 2019;90(Suppl 3):5–10. doi: 10.23750/abm.v90i3-S.8149

Table 1.

Classification of drug allergies

Type of immune response Physiopathology Main clinical symptoms Chronology (after the drug)
IgE mediated Mast cell, basophil degranulation Anaphylaxis, angioedema, urticaria, rhinitis, asthma within 6 hours after the last intake
IgG and complement IgG and complement-Dependent cytotoxicity Cytopenia 5-15 days after the start
IgM or IgG and complement or FcR Deposition of immune complexes Vaculitis, Serum sickness 7-21 days after the start 7-8 days after the start
Th1 (IFN-γ) Monocytes inflammation Dermatitis within 21 days after the start
Th2 (IL-4 and IL-5) Eosinophilic inflammation Maculopapular exanthema DRESS several days after the start 2-6 weeks after the start
Cytotoxic T cells (perforin, granzyme B, FasL) Keratinocyte death mediated by CD4 or CD8 SJS/TEN 4-28 days after the start
T cells (IL-8/CXCL8) exanthematous pustulosis Neutrophil inflammation Acute generalized 1 to several days